Moreover, we observed that high FOXC2 in expression GC tissues was significantly associated with more aggressive tumor phenotypes (Table 2) and shorter overall survival of GC patients than in patients with lower FOXC2 expression, as confirmed using the Kaplan-Meier plotter database (Figure 6C). This evidence concerns the gene FOXC2 and neoplasm.